AI mRS Scoring Validation Study, Stroke, Apr 22
Summary
ClinicalTrials.gov study NCT07544927 is an observational trial registered in April 2026 to validate an AI-based automatic scoring system for the Modified Rankin Scale (mRS) in stroke patients. The study compares AI-generated mRS scores against standardized manual assessments performed by trained professionals to evaluate consistency and accuracy. The stated goal is to provide a convenient, efficient, and objective tool for stroke prognosis assessment, reduce subjective variability of manual scoring, and optimize the stroke follow-up workflow. Condition under study: Stroke. Study type: Observational.
About this source
GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 686 changes logged to date.
What changed
ClinicalTrials.gov study NCT07544927 is an observational registry for a clinical validation study of an AI-based automatic scoring system for the Modified Rankin Scale (mRS) in stroke patients. The study aims to assess consistency and accuracy between AI-generated scores and standardized manual mRS follow-up assessments performed by trained professionals. No compliance obligations are created by this registry.\n\nFor clinical researchers and healthcare institutions developing or evaluating AI-based clinical assessment tools, this study design may serve as a reference methodology for validation studies. Institutions using mRS in stroke care or clinical trials may wish to monitor AI-based scoring developments that could affect follow-up workflow and outcome assessment standardization.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Clinical Validation of an Artificial Intelligence-Based Scoring System for the Modified Rankin Scale (mRS) in Patients With Stroke
Observational NCT07544927 Kind: OBSERVATIONAL Apr 22, 2026
Abstract
This study aims to validate the clinical performance of an artificial intelligence (AI)-based automatic scoring system for the Modified Rankin Scale (mRS). The core comparison is the consistency and accuracy between the AI-generated scores and standardized manual mRS follow-up assessments performed by trained professionals. The goal is to provide a convenient, efficient, and objective tool for stroke prognosis assessment, reduce the subjective variability of manual scoring, and optimize the stroke follow-up workflow.
Conditions: Stroke
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.